Sanofi pockets $17B in sell-off

Posted 2 May 2025 PM

Sanofi has collected a cool AU$17.6 billion (10 billion euros) after closing a deal to sell off a controlling stake in its consumer health business Opella.

US private equity firm Clayton, Dubilier & Rice (CB&R) have a 50 per cent shareholding in Opella while Sanofi still retains a significant stake of 48.2 per cent. Bpifrance takes on a 1.8 per cent stake and will join the Opella Board.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here